27/06/2025

Search Posts biopharmaceutical Page 2

Celltrion Secures Interchangeability Approval for Humira Biosimilar in the U.S.

Celltrion Secures Interchangeability Approval for Humira Biosimilar in the U.S.

April 14, 2025

Samsung Leads Domestic Sales for 22 Years: Analysis

Samsung Leads Domestic Sales for 22 Years: Analysis

March 24, 2025

Celltrion Aims for $3.46 Billion in Sales This Year Powered by Biosimilars

Celltrion Aims for $3.46 Billion in Sales This Year Powered by Biosimilars

March 18, 2025

Celltrion Unveils New Treatment for Autoimmune Disorders in the US

Celltrion Unveils New Treatment for Autoimmune Disorders in the US

March 13, 2025

Celltrion Secures USFDA Nod for Allergic Asthma Biosimilar

Celltrion Secures USFDA Nod for Allergic Asthma Biosimilar

March 10, 2025

Celltrion's Biosimilars for Bone Disorders Gain US Approval

Celltrion's Biosimilars for Bone Disorders Gain US Approval

March 4, 2025

South Korea to Allocate $809.3 Million for Advanced Materials Technology

South Korea to Allocate $809.3 Million for Advanced Materials Technology

February 4, 2025

South Korea Aims to Join Top 5 Global Biotechnology Leaders by 2027

South Korea Aims to Join Top 5 Global Biotechnology Leaders by 2027

January 15, 2025

Celltrion Secures Approval for Biosimilar Allergic Asthma Treatment in Canada

Celltrion Secures Approval for Biosimilar Allergic Asthma Treatment in Canada

December 9, 2024

South Korea Penalizes Pharma Leader Celltrion for Unfair Trade Conduct

South Korea Penalizes Pharma Leader Celltrion for Unfair Trade Conduct

December 3, 2024

1
2